Specific Heart Muscle Disease presents the primary syndromes in which heart muscle disease is an intrinsic part of another clinical syndrome. This book discusses the cardiomyopathies and shows how they are related to the different forms of specific heart muscle disease. Organized into 11 chapters, this book begins with an overview of the recognition of the various types of cardiomyopathy based on a detailed analysis of function and structure. This text then examines the structure of the amyloid fibril and the pattern of deposition of it in the body. Other chapters consider the possible link between endomyocardial disease and adherent thrombi. This book discusses as well the therapeutic measures to remove the majority of the iron load in hemochromatosis. The final chapter deals with the survival rates in cardiac transplantation and reviews some of the homograft pathology affecting survival in long-term cardiac recipients. This book is a valuable resource for cardiologists and general physicians.
Inhaltsverzeichnis
1;Front Cover;1 2;Specific Heart Muscle Disease;4 3;Copyright Page;5 4;Table of Contents;10 5;Preface;6 6;Contributors;8 7;Foreword;12 8;Chapter 1. Terminology of disorders of cardiac muscle;14 8.1;INTRODUCTION;14 8.2;PERIPARTAL HEART DISEASE;19 8.3;DIABETIC HEART DISEASE;20 8.4;THE CONNECTIVE TISSUE DISORDERS;21 8.5;THE RELATIONSHIP OF MYOCARDITIS TO CARDIOMYOPATHY;23 8.6;REFERENCES;24 9;Chapter 2. Amyloid heart disease;26 9.1;INTRODUCTION;26 9.2;PATHOLOGY;27 9.3;CLINICAL FEATURES;28 9.4;INVESTIGATIONS;29 9.5;TREATMENT;32 9.6;DIFFERENTIAL DIAGNOSIS;32 9.7;REFERENCES;35 10;Chapter 3. Eosinophilic heart disease;37 10.1;INTRODUCTION;37 10.2;AETIOLOGY;38 10.3;PATHOLOGY;39 10.4;CARDIOVASCULAR FINDINGS;40 10.5;INVESTIGATIONS;40 10.6;NATURAL HISTORY;42 10.7;TREATMENT;44 10.8;REFERENCES;44 11;Chapter 4. Cardiac disease associated with iron overload;46 11.1;ACKNOWLEDGEMENT;56 11.2;REFERENCES;56 12;Chapter 5. Cardiac abnormalities associated with hereditary neuromuscular diseases;59 12.1;FRIEDREICH'S ATAXIA;59 12.2;DUCHENNE'S MUSCULAR DYSTROPHY;62 12.3;BECKER'S DYSTROPHY AND LIMB GIRDLE DYSTROPHY OF ERB;66 12.4;FACIO-SCAPULOHUMERAL DYSTROPHY (LANDOUZYDEJERINE SYNDROME);66 12.5;DYSTROPHIA MYOTONIA;67 12.6;SCAPULOPERONEAL SYNDROME;69 12.7;CHARCOTMARIETOOTH DISEASE (PERONEAL MUSCULAR ATROPHY);69 12.8;HUMEROPERONEAL DYSTROPHY;70 12.9;REFERENCES;70 13;Chapter 6. Acromegalic heart disease;75 13.1;INTRODUCTION;75 13.2;CLINICAL STUDIES;76 13.3;ANIMAL STUDIES;81 13.4;CONCLUSIONS;86 13.5;ACKNOWLEDGEMENTS;86 13.6;REFERENCES;86 14;Chapter 7. Thyroid heart disease;88 14.1;INTRODUCTION;88 14.2;ACTION OF THYROID HORMONES ON THE HEART;89 14.3;HYPOTHYROIDISM;91 14.4;HYPERTHYROIDISM;95 14.5;HEART MUSCLE DISEASE;96 14.6;CONCLUSIONS;99 14.7;REFERENCES;100 15;Chapter 8. Sarcoid heart disease;103 15.1;INTRODUCTION;103 15.2;SARCOID HEART DISEASE: THE BRITISH STUDY;104 15.3;FURTHER INVESTIGATION;110 15.4;TREATMENT;110 15.5;CONCLUSIONS;110 15.6;ACKNOWLEDGMENTS;111 15.7;REFERENCES;111 16;Chapter 9. A
lcohol-induced heart muscle disease;112 16.1;INTRODUCTION;112 16.2;POPULATION AT RISK;115 16.3;DEFINITION;115 16.4;RELATION BETWEEN ALCOHOL CONSUMPTION AND MYOCARDIAL DISEASE;115 16.5;EPIDEMIOLOGY;116 16.6;PATHOGENIC MECHANISMS;117 16.7;PHYSIOLOGICAL EFFECTS OF ALCOHOL;119 16.8;PATHOLOGY;119 16.9;CLINICAL PRESENTATION;123 16.10;INVESTIGATIONS;124 16.11;INVASIVE ASSESSMENT OF ALCOHOLIC HEART DISEASE;128 16.12;DIAGNOSIS;131 16.13;TREATMENT;131 16.14;CONCLUSION;132 16.15;ACKNOWLEDGEMENTS;133 16.16;REFERENCES;133 17;Chapter 10. Drug toxicity and the heart: potential molecular mechanisms;136 17.1;CALCIUM OVERLOAD';136 17.2;FREE RADICAL FORMATION;137 17.3;VASCULAR (ISCHAEMIA)-MEDIATED MYOCARDIAL INJURY;137 17.4;NUTRITIONALMETABOLIC CAUSES;138 17.5;VASOACTIVE SUBSTANCES AND ABNORMALITIES IN CELLULAR HORMONE RECEPTORS;139 17.6;REFERENCES;140 18;Chapter 11. Diseases of the transplanted heart;143 18.1;INTRODUCTION;143 18.2;PROBLEMS FOLLOWING HEART TRANSPLANTATION;145 18.3;DONOR HEART PRESERVATION FOR CARDIAC TRANSPLANTATION;149 18.4;MORPHOLOGICAL STUDIES ON LONG-TERM SURVIVORS OF CARDIAC TRANSPLANTATION;151 18.5;REFERENCES;151 19;Index;154